[go: up one dir, main page]

MX2020008897A - Expansion y diferenciacion de citoblastos. - Google Patents

Expansion y diferenciacion de citoblastos.

Info

Publication number
MX2020008897A
MX2020008897A MX2020008897A MX2020008897A MX2020008897A MX 2020008897 A MX2020008897 A MX 2020008897A MX 2020008897 A MX2020008897 A MX 2020008897A MX 2020008897 A MX2020008897 A MX 2020008897A MX 2020008897 A MX2020008897 A MX 2020008897A
Authority
MX
Mexico
Prior art keywords
differentiation
expansion
stem cells
cells
stem
Prior art date
Application number
MX2020008897A
Other languages
English (en)
Inventor
Anthony Steven Weiss
Giselle Yeo
Original Assignee
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018900663A external-priority patent/AU2018900663A0/en
Application filed by Allergan Pharmaceuticals Int Ltd filed Critical Allergan Pharmaceuticals Int Ltd
Publication of MX2020008897A publication Critical patent/MX2020008897A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0654—Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/46—Amines, e.g. putrescine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/105—Insulin-like growth factors [IGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/80—Hyaluronan
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La descripción se relaciona con la expansión y diferenciación de citoblastos del mesénquima y células de médula ósea, que incluyen retención de plasticidad de citoblastos durante la expansión y diferenciación de citoblastos para producir osteocitos, condrocitos y otras células de la línea mesodérmica.
MX2020008897A 2018-03-01 2019-03-01 Expansion y diferenciacion de citoblastos. MX2020008897A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2018900663A AU2018900663A0 (en) 2018-03-01 Expansion and differentiation of stem cells
PCT/EP2019/055186 WO2019166643A1 (en) 2018-03-01 2019-03-01 Expansion and differentiation of stem cells

Publications (1)

Publication Number Publication Date
MX2020008897A true MX2020008897A (es) 2021-01-08

Family

ID=65686842

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020008897A MX2020008897A (es) 2018-03-01 2019-03-01 Expansion y diferenciacion de citoblastos.

Country Status (9)

Country Link
US (1) US20190275087A1 (es)
EP (1) EP3759214A1 (es)
JP (1) JP2021514676A (es)
CN (1) CN111868230A (es)
AU (1) AU2019228726A1 (es)
BR (1) BR112020017494A2 (es)
CA (1) CA3091946A1 (es)
MX (1) MX2020008897A (es)
WO (1) WO2019166643A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111996162B (zh) * 2020-09-08 2022-03-04 依科赛生物科技（太仓）有限公司 一种成软骨分化培养基及其应用
CN112920995A (zh) * 2021-03-31 2021-06-08 赵峻岭 一种间充质干细胞培养血清加油包及其应用
CN113913376A (zh) * 2021-12-03 2022-01-11 北京吉中科生物技术有限公司 一种人源脐带来源间充质干细胞的优化培养基、试剂盒及组织贴壁培养方法
CN114574436A (zh) * 2022-05-06 2022-06-03 深圳汉盛汇融再生医学科技有限公司 一种治疗膝关节退行性病变的干细胞制剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6232458B1 (en) 1992-12-22 2001-05-15 The University Of Sydney Synthetic polynucleotides encoding tropoelastin
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
JP4388483B2 (ja) * 2004-12-27 2009-12-24 株式会社ツーセル 間葉系幹細胞の骨化及び／又は軟骨化促進剤と骨化及び／又は軟骨化促進方法
WO2012129109A2 (en) * 2011-03-18 2012-09-27 New York Blood Center, Inc. Megakaryocyte and platelet production from stem cells
CN104662532B (zh) * 2011-03-28 2018-09-07 约翰·S·阿诺尼 基于干细胞的化妆配制品及制备其的方法和系统
KR102527367B1 (ko) * 2011-09-30 2023-04-28 엘라스타겐 피티와이 리미티드 탄력섬유의 생체 내 합성

Also Published As

Publication number Publication date
WO2019166643A1 (en) 2019-09-06
CN111868230A (zh) 2020-10-30
US20190275087A1 (en) 2019-09-12
CA3091946A1 (en) 2019-09-06
EP3759214A1 (en) 2021-01-06
JP2021514676A (ja) 2021-06-17
AU2019228726A1 (en) 2020-09-10
BR112020017494A2 (pt) 2020-12-22

Similar Documents

Publication Publication Date Title
MX2020008897A (es) Expansion y diferenciacion de citoblastos.
MX2019008872A (es) Prevencion y tratamiento de da?o o enfermedad osea y cartilago.
CL2019000540A1 (es) Método para aislar células madre mesenquimales a partir de membrana amniótica de cordón umbilical utilizando un medio de cultivo celular resumen de la invención.
AR111835A1 (es) Composiciones estables de inoculantes que comprenden aceites vegetales metilados
CL2024000734A1 (es) Composiciones y métodos para la generación in vivo de células que expresan car.
MX2020005849A (es) Células madre y progenitoras hematopoyéticas humanas cd34+ modificadas con crispr-cas9 y sus usos.
BR112021019349A2 (pt) Células-tronco preparadas altamente funcionais
NI201100083A (es) Compuestos que expanden células madre hematopoyéticas.
BR112022011169A2 (pt) Métodos para geração de células-tronco hematopoiéticas
PH12021551100A1 (en) Dried biological compositions and methods thereof
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
MX2021009967A (es) Metodos para producir celulas t autologas utiles para tratar cancer y composiciones de las mismas.
MX387296B (es) Proliferacion ex vivo de celulas epiteliales.
BR112014032074A2 (pt) construções de tecido conjuntivo tridimensionais engendradas e métodos de fabricar as mesmas
MX383334B (es) Celulas discogenicas aisladas, metodos de uso, y metodos de preparacion de las mismas a partir de tejido de mamifero.
DOP2013000240A (es) Composiciones y métodos para transferencia de energía mitocondrial de línea germinal autóloga
MX2021012041A (es) Metodos para promover la diferenciacion de celulas epiteliales timicas y progenitores de celulas epiteliales timicas de celulas madre pluripotentes, celulas resultantes y usos de estas.
WO2016168890A8 (en) Generation of muscle-lineage cells from stem cells
BR112018069090A2 (pt) tratamento de câncer com base na distribuição de oligos por meio de junções comunicantes a partir de células estaminais mesenquimatosas humanas (hmsc)
PH12018502061A1 (en) Differentiation of pluripotent stem cells to intestinal midgut endoderm cells
PH12020551658A1 (en) A method of inducing or improving wound healing properties of mesenchymal stem cells
MX2016016756A (es) Terapia con células madre en patologías endometriales.
AR120475A1 (es) Producción de células precursoras hematopoyéticas
MX2021003219A (es) Biomaterial que comprende celulas germinales derivadas de tejido adiposo y gelatina y metodo para producir el mismo.
BR112016021395A8 (pt) métodos de geração de uma célula pluripotente e de preparação de uma célula ou tecido ensaio, uso de uma célula pluripotente, e, composição